ArticleNature communications2022

A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases.

Atsuhiro Yasuhara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.